share_log

Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Espinoza Octavio

SEC announcement ·  Dec 6, 2023 15:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more